Iodine in PDB 6qe4: Re-Refinement of 5OLI Human IBA57-I3C
Protein crystallography data
The structure of Re-Refinement of 5OLI Human IBA57-I3C, PDB code: 6qe4
was solved by
V.Calderone,
S.Ciofi-Baffoni,
S.Gourdoupis,
L.Banci,
V.Nasta,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
56.84 /
2.30
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
38.111,
43.048,
59.281,
77.92,
75.63,
71.67
|
R / Rfree (%)
|
20.6 /
22.8
|
Iodine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
12;
Binding sites:
The binding sites of Iodine atom in the Re-Refinement of 5OLI Human IBA57-I3C
(pdb code 6qe4). This binding sites where shown within
5.0 Angstroms radius around Iodine atom.
In total 12 binding sites of Iodine where determined in the
Re-Refinement of 5OLI Human IBA57-I3C, PDB code: 6qe4:
Jump to Iodine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Iodine binding site 1 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 1 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 1 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I401
b:21.5
occ:0.60
|
I3
|
A:I3C401
|
0.0
|
21.5
|
0.6
|
C6
|
A:I3C401
|
2.0
|
27.3
|
0.6
|
C1
|
A:I3C401
|
3.0
|
29.4
|
0.6
|
C5
|
A:I3C401
|
3.0
|
27.7
|
0.6
|
C7
|
A:I3C401
|
3.2
|
28.4
|
0.6
|
N13
|
A:I3C401
|
3.2
|
26.1
|
0.6
|
O
|
A:LEU292
|
3.3
|
32.5
|
1.0
|
O8
|
A:I3C401
|
3.6
|
27.4
|
0.6
|
O9
|
A:I3C401
|
3.7
|
28.9
|
0.6
|
CA
|
A:GLY279
|
3.7
|
30.9
|
1.0
|
CD
|
A:LYS248
|
3.8
|
56.4
|
1.0
|
CD2
|
A:LEU292
|
4.0
|
34.1
|
1.0
|
C
|
A:GLY279
|
4.0
|
32.8
|
1.0
|
CG
|
A:LEU292
|
4.1
|
31.3
|
1.0
|
C
|
A:LEU292
|
4.1
|
31.5
|
1.0
|
N
|
A:LYS280
|
4.1
|
29.1
|
1.0
|
C2
|
A:I3C401
|
4.3
|
31.3
|
0.6
|
CD1
|
A:TRP294
|
4.3
|
54.2
|
1.0
|
C4
|
A:I3C401
|
4.4
|
31.5
|
0.6
|
N
|
A:GLY279
|
4.4
|
34.9
|
1.0
|
CB
|
A:LEU292
|
4.5
|
26.2
|
1.0
|
CG
|
A:LYS248
|
4.5
|
43.4
|
1.0
|
O
|
A:VAL278
|
4.6
|
36.3
|
1.0
|
NE1
|
A:TRP294
|
4.7
|
55.1
|
1.0
|
CB
|
A:LYS280
|
4.7
|
31.7
|
1.0
|
O
|
A:GLY279
|
4.7
|
35.1
|
1.0
|
CD
|
A:LYS280
|
4.8
|
50.8
|
1.0
|
C
|
A:VAL278
|
4.8
|
37.7
|
1.0
|
N
|
A:LEU293
|
4.8
|
29.0
|
1.0
|
CA
|
A:LEU293
|
4.8
|
32.0
|
1.0
|
NZ
|
A:LYS248
|
4.9
|
78.2
|
1.0
|
C3
|
A:I3C401
|
4.9
|
32.1
|
0.6
|
CE
|
A:LYS280
|
4.9
|
50.2
|
1.0
|
CE
|
A:LYS248
|
4.9
|
68.0
|
1.0
|
CG
|
A:LYS280
|
5.0
|
45.2
|
1.0
|
CA
|
A:LEU292
|
5.0
|
25.8
|
1.0
|
CB
|
A:LYS248
|
5.0
|
31.9
|
1.0
|
|
Iodine binding site 2 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 2 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 2 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I401
b:33.0
occ:0.60
|
I2
|
A:I3C401
|
0.0
|
33.0
|
0.6
|
C4
|
A:I3C401
|
2.0
|
31.5
|
0.6
|
C3
|
A:I3C401
|
3.0
|
32.1
|
0.6
|
C5
|
A:I3C401
|
3.0
|
27.7
|
0.6
|
N13
|
A:I3C401
|
3.2
|
26.1
|
0.6
|
C10
|
A:I3C401
|
3.3
|
33.4
|
0.6
|
O11
|
A:I3C401
|
3.6
|
33.0
|
0.6
|
O
|
A:THR277
|
3.8
|
48.7
|
1.0
|
O12
|
A:I3C401
|
3.9
|
33.5
|
0.6
|
C2
|
A:I3C401
|
4.3
|
31.3
|
0.6
|
CG2
|
A:THR277
|
4.3
|
50.1
|
1.0
|
C6
|
A:I3C401
|
4.4
|
27.3
|
0.6
|
NE1
|
A:TRP294
|
4.5
|
55.1
|
1.0
|
CB
|
A:THR277
|
4.5
|
55.2
|
1.0
|
C
|
A:THR277
|
4.7
|
48.4
|
1.0
|
C1
|
A:I3C401
|
4.9
|
29.4
|
0.6
|
|
Iodine binding site 3 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 3 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 3 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I401
b:32.8
occ:0.60
|
I1
|
A:I3C401
|
0.0
|
32.8
|
0.6
|
C2
|
A:I3C401
|
2.0
|
31.3
|
0.6
|
C1
|
A:I3C401
|
3.0
|
29.4
|
0.6
|
C3
|
A:I3C401
|
3.0
|
32.1
|
0.6
|
C7
|
A:I3C401
|
3.2
|
28.4
|
0.6
|
C10
|
A:I3C401
|
3.2
|
33.4
|
0.6
|
O12
|
A:I3C401
|
3.4
|
33.5
|
0.6
|
O9
|
A:I3C401
|
3.5
|
28.9
|
0.6
|
O8
|
A:I3C401
|
3.7
|
27.4
|
0.6
|
O11
|
A:I3C401
|
3.8
|
33.0
|
0.6
|
NZ
|
A:LYS248
|
4.0
|
78.2
|
1.0
|
NZ
|
A:LYS280
|
4.0
|
53.1
|
1.0
|
C6
|
A:I3C401
|
4.3
|
27.3
|
0.6
|
C4
|
A:I3C401
|
4.3
|
31.5
|
0.6
|
C5
|
A:I3C401
|
4.9
|
27.7
|
0.6
|
|
Iodine binding site 4 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 4 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 4 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I402
b:43.4
occ:0.40
|
I3
|
A:I3C402
|
0.0
|
43.4
|
0.4
|
C6
|
A:I3C402
|
2.0
|
41.3
|
0.4
|
C1
|
A:I3C402
|
3.0
|
38.5
|
0.4
|
C5
|
A:I3C402
|
3.0
|
42.4
|
0.4
|
N13
|
A:I3C402
|
3.2
|
43.1
|
0.4
|
C7
|
A:I3C402
|
3.2
|
36.7
|
0.4
|
O9
|
A:I3C402
|
3.5
|
36.2
|
0.4
|
O8
|
A:I3C402
|
3.8
|
36.1
|
0.4
|
CZ2
|
A:TRP188
|
4.1
|
29.1
|
1.0
|
OD1
|
A:ASN287
|
4.2
|
66.7
|
1.0
|
CA
|
A:GLY286
|
4.2
|
31.9
|
1.0
|
N
|
A:ASN287
|
4.2
|
34.6
|
1.0
|
C2
|
A:I3C402
|
4.3
|
36.7
|
0.4
|
C4
|
A:I3C402
|
4.3
|
42.6
|
0.4
|
C
|
A:GLY286
|
4.6
|
37.3
|
1.0
|
CH2
|
A:TRP188
|
4.7
|
30.3
|
1.0
|
C3
|
A:I3C402
|
4.8
|
40.2
|
0.4
|
CB
|
A:ASN287
|
4.8
|
39.5
|
1.0
|
CG
|
A:ASN287
|
4.9
|
73.9
|
1.0
|
|
Iodine binding site 5 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 5 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 5 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I402
b:44.5
occ:0.40
|
I2
|
A:I3C402
|
0.0
|
44.5
|
0.4
|
C4
|
A:I3C402
|
2.0
|
42.6
|
0.4
|
C3
|
A:I3C402
|
3.0
|
40.2
|
0.4
|
C5
|
A:I3C402
|
3.0
|
42.4
|
0.4
|
N13
|
A:I3C402
|
3.2
|
43.1
|
0.4
|
C10
|
A:I3C402
|
3.2
|
40.8
|
0.4
|
O12
|
A:I3C402
|
3.6
|
42.1
|
0.4
|
O11
|
A:I3C402
|
3.8
|
39.9
|
0.4
|
C6
|
A:I3C402
|
4.3
|
41.3
|
0.4
|
C2
|
A:I3C402
|
4.3
|
36.7
|
0.4
|
CG
|
A:ASN287
|
4.7
|
73.9
|
1.0
|
C1
|
A:I3C402
|
4.8
|
38.5
|
0.4
|
CB
|
A:ASN287
|
4.8
|
39.5
|
1.0
|
ND2
|
A:ASN287
|
4.8
|
71.3
|
1.0
|
|
Iodine binding site 6 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 6 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 6 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I402
b:31.4
occ:0.40
|
I1
|
A:I3C402
|
0.0
|
31.4
|
0.4
|
C2
|
A:I3C402
|
2.0
|
36.7
|
0.4
|
C1
|
A:I3C402
|
3.0
|
38.5
|
0.4
|
C3
|
A:I3C402
|
3.0
|
40.2
|
0.4
|
C7
|
A:I3C402
|
3.2
|
36.7
|
0.4
|
C10
|
A:I3C402
|
3.2
|
40.8
|
0.4
|
O11
|
A:I3C402
|
3.5
|
39.9
|
0.4
|
O8
|
A:I3C402
|
3.5
|
36.1
|
0.4
|
O9
|
A:I3C402
|
3.7
|
36.2
|
0.4
|
O12
|
A:I3C402
|
3.8
|
42.1
|
0.4
|
CG1
|
A:VAL288
|
3.9
|
33.0
|
1.0
|
O
|
A:HOH518
|
3.9
|
44.3
|
1.0
|
NE2
|
A:GLN192
|
4.0
|
40.6
|
1.0
|
CG
|
A:GLN192
|
4.1
|
33.4
|
1.0
|
CD
|
A:GLN192
|
4.2
|
52.1
|
1.0
|
C6
|
A:I3C402
|
4.3
|
41.3
|
0.4
|
C4
|
A:I3C402
|
4.3
|
42.6
|
0.4
|
CG2
|
A:VAL288
|
4.3
|
30.9
|
1.0
|
CD1
|
A:LEU196
|
4.4
|
31.3
|
1.0
|
CD2
|
A:LEU196
|
4.7
|
34.4
|
1.0
|
CB
|
A:VAL288
|
4.7
|
31.9
|
1.0
|
CG
|
A:LEU196
|
4.8
|
30.6
|
1.0
|
OE1
|
A:GLN192
|
4.9
|
53.0
|
1.0
|
C5
|
A:I3C402
|
4.9
|
42.4
|
0.4
|
|
Iodine binding site 7 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 7 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 7 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I403
b:42.2
occ:0.40
|
I3
|
A:I3C403
|
0.0
|
42.2
|
0.4
|
C6
|
A:I3C403
|
2.0
|
42.2
|
0.4
|
C1
|
A:I3C403
|
3.0
|
42.7
|
0.4
|
C5
|
A:I3C403
|
3.0
|
41.3
|
0.4
|
C7
|
A:I3C403
|
3.2
|
42.3
|
0.4
|
N13
|
A:I3C403
|
3.2
|
40.6
|
0.4
|
O9
|
A:I3C403
|
3.5
|
41.8
|
0.4
|
NZ
|
A:LYS119
|
3.7
|
1.0
|
1.0
|
O8
|
A:I3C403
|
3.7
|
42.4
|
0.4
|
C2
|
A:I3C403
|
4.3
|
44.0
|
0.4
|
C4
|
A:I3C403
|
4.3
|
40.5
|
0.4
|
C3
|
A:I3C403
|
4.8
|
43.0
|
0.4
|
|
Iodine binding site 8 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 8 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 8 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I403
b:38.5
occ:0.40
|
I2
|
A:I3C403
|
0.0
|
38.5
|
0.4
|
C4
|
A:I3C403
|
2.0
|
40.5
|
0.4
|
C5
|
A:I3C403
|
3.0
|
41.3
|
0.4
|
C3
|
A:I3C403
|
3.0
|
43.0
|
0.4
|
N13
|
A:I3C403
|
3.2
|
40.6
|
0.4
|
C10
|
A:I3C403
|
3.3
|
44.7
|
0.4
|
O12
|
A:I3C403
|
3.6
|
45.2
|
0.4
|
CD
|
A:PRO35
|
3.8
|
67.4
|
1.0
|
O11
|
A:I3C403
|
3.9
|
45.6
|
0.4
|
C6
|
A:I3C403
|
4.3
|
42.2
|
0.4
|
C2
|
A:I3C403
|
4.4
|
44.0
|
0.4
|
CG
|
A:PRO35
|
4.4
|
73.5
|
1.0
|
CD
|
A:LYS119
|
4.6
|
0.7
|
1.0
|
C1
|
A:I3C403
|
4.9
|
42.7
|
0.4
|
NZ
|
A:LYS119
|
4.9
|
1.0
|
1.0
|
CB
|
A:LYS119
|
4.9
|
77.8
|
1.0
|
|
Iodine binding site 9 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 9 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 9 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I403
b:45.5
occ:0.40
|
I1
|
A:I3C403
|
0.0
|
45.5
|
0.4
|
C2
|
A:I3C403
|
2.0
|
44.0
|
0.4
|
C1
|
A:I3C403
|
3.0
|
42.7
|
0.4
|
C3
|
A:I3C403
|
3.0
|
43.0
|
0.4
|
C7
|
A:I3C403
|
3.1
|
42.3
|
0.4
|
C10
|
A:I3C403
|
3.3
|
44.7
|
0.4
|
O11
|
A:I3C403
|
3.4
|
45.6
|
0.4
|
O8
|
A:I3C403
|
3.5
|
42.4
|
0.4
|
O
|
A:VAL120
|
3.5
|
63.8
|
1.0
|
O9
|
A:I3C403
|
3.8
|
41.8
|
0.4
|
CG2
|
A:THR121
|
3.8
|
67.1
|
1.0
|
O12
|
A:I3C403
|
3.9
|
45.2
|
0.4
|
N
|
A:VAL120
|
3.9
|
65.2
|
1.0
|
C
|
A:VAL120
|
4.1
|
61.1
|
1.0
|
C6
|
A:I3C403
|
4.3
|
42.2
|
0.4
|
C4
|
A:I3C403
|
4.4
|
40.5
|
0.4
|
CA
|
A:LYS119
|
4.5
|
73.7
|
1.0
|
C
|
A:LYS119
|
4.6
|
69.1
|
1.0
|
CA
|
A:VAL120
|
4.6
|
59.6
|
1.0
|
O
|
A:ARG118
|
4.7
|
75.6
|
1.0
|
N
|
A:THR121
|
4.7
|
56.8
|
1.0
|
C5
|
A:I3C403
|
4.9
|
41.3
|
0.4
|
|
Iodine binding site 10 out
of 12 in 6qe4
Go back to
Iodine Binding Sites List in 6qe4
Iodine binding site 10 out
of 12 in the Re-Refinement of 5OLI Human IBA57-I3C
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 10 of Re-Refinement of 5OLI Human IBA57-I3C within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I404
b:23.7
occ:0.40
|
I3
|
A:I3C404
|
0.0
|
23.7
|
0.4
|
C6
|
A:I3C404
|
2.1
|
30.4
|
0.4
|
O9
|
A:I3C404
|
3.0
|
36.3
|
0.4
|
C5
|
A:I3C404
|
3.1
|
35.1
|
0.4
|
C1
|
A:I3C404
|
3.1
|
33.4
|
0.4
|
N13
|
A:I3C404
|
3.2
|
33.8
|
0.4
|
O
|
A:ASP159
|
3.3
|
20.9
|
1.0
|
C7
|
A:I3C404
|
3.4
|
34.6
|
0.4
|
O
|
A:PRO160
|
3.8
|
20.1
|
1.0
|
C
|
A:PRO160
|
4.0
|
19.6
|
1.0
|
N
|
A:ALA163
|
4.1
|
24.4
|
1.0
|
CA
|
A:THR162
|
4.1
|
21.0
|
1.0
|
N
|
A:THR162
|
4.1
|
19.6
|
1.0
|
C
|
A:THR162
|
4.1
|
23.7
|
1.0
|
CA
|
A:PRO160
|
4.2
|
17.7
|
1.0
|
O
|
A:HOH507
|
4.3
|
33.0
|
1.0
|
C4
|
A:I3C404
|
4.4
|
42.0
|
0.4
|
O8
|
A:I3C404
|
4.4
|
34.0
|
0.4
|
C
|
A:ASP159
|
4.5
|
20.6
|
1.0
|
C2
|
A:I3C404
|
4.5
|
35.0
|
0.4
|
OD1
|
A:ASN222
|
4.5
|
30.1
|
1.0
|
C
|
A:ARG161
|
4.5
|
20.4
|
1.0
|
N
|
A:ARG161
|
4.6
|
17.7
|
1.0
|
O
|
A:THR162
|
4.8
|
22.5
|
1.0
|
CA
|
A:ALA163
|
4.9
|
25.8
|
1.0
|
N
|
A:PRO160
|
4.9
|
17.4
|
1.0
|
O
|
A:HOH546
|
4.9
|
33.4
|
1.0
|
O
|
A:ARG161
|
4.9
|
20.4
|
1.0
|
C3
|
A:I3C404
|
5.0
|
38.6
|
0.4
|
|
Reference:
S.Gourdoupis,
V.Nasta,
S.Ciofi-Baffoni,
L.Banci,
V.Calderone.
In-House High-Energy-Remote Sad Phasing Using the Magic Triangle: How to Tackle the P1 Low Symmetry Using Multiple Orientations of the Same Crystal of Human IBA57 to Increase the Multiplicity. Acta Crystallogr D Struct V. 75 317 2019BIOL.
ISSN: ISSN 2059-7983
PubMed: 30950402
DOI: 10.1107/S2059798319000214
Page generated: Sun Aug 11 23:57:05 2024
|